SMA carrier testing – validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion (original) (raw)
- Article
- Published: 16 March 2000
- Jan Maarten Cobben1,
- Rob GJ Mensink1,
- Rein P Stulp1,
- Gerrit van der Steege1 &
- …
- Charles HCM Buys1
European Journal of Human Genetics volume 8, pages 79–86 (2000)Cite this article
- 1332 Accesses
- 46 Citations
- Metrics details
Abstract
To facilitate the detection of carriers of a hemizygous survival motor neuron (SMN) exon 7 deletion we have modified the quantitative SMN exon 7 assay described by McAndrew et al (1997). The major changes include quantitative analysis of the amount of SMN exon 7-specific fluorescently-labelled PCR product on an automated sequencer, and the monitoring of the completeness of a DraI digestion necessary to distinguish the PCR products of exons 7 of SMN and its copy gene. In our method the amount of SMN exon 7 PCR product is compared with the amount of a co-amplified PCR product of the retinoblastoma (RB1) exon containing a DraI restriction site. By co-amplification using the same primers of plasmids included in the reaction as internal standards containing SMN exon 7 with a 36-nucleotide deletion and RB1 exon 13 with a 19-nucleotide deletion, respectively, the relative amplification efficacy can be monitored. The assay has been validated in 63 ascertained carriers and 28 ascertained non-carriers. The sensitivity of the test is approximately 97%, the specificity approaches 100%. In four out of six SMA patients without a homozygous deletion we detected a hemizygous deletion. The implications of the use of this assay for carrier testing and for confirmation of the clinical diagnosis of SMA are discussed.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
- Department of Medical Genetics, University of Groningen, The Netherlands
Hans Scheffer, Jan Maarten Cobben, Rob GJ Mensink, Rein P Stulp, Gerrit van der Steege & Charles HCM Buys
Authors
- Hans Scheffer
You can also search for this author inPubMed Google Scholar - Jan Maarten Cobben
You can also search for this author inPubMed Google Scholar - Rob GJ Mensink
You can also search for this author inPubMed Google Scholar - Rein P Stulp
You can also search for this author inPubMed Google Scholar - Gerrit van der Steege
You can also search for this author inPubMed Google Scholar - Charles HCM Buys
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toHans Scheffer.
Rights and permissions
About this article
Cite this article
Scheffer, H., Cobben, J., Mensink, R. et al. SMA carrier testing – validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion.Eur J Hum Genet 8, 79–86 (2000). https://doi.org/10.1038/sj.ejhg.5200404
- Received: 07 June 1999
- Revised: 27 August 1999
- Accepted: 02 September 1999
- Published: 16 March 2000
- Issue Date: 01 February 2000
- DOI: https://doi.org/10.1038/sj.ejhg.5200404